Caixin Global – Latest China News & Headlines

Home >


CX Tech is Caixin Global's real-time tech news portal, featuring 24-hour news, short-form analysis, and roundups from business and tech media in China.

Shanghai-Based Robot Developer Closes $46 Million Funding Round
Trending in China: Top Broadcast Exec Questions if Esports Are Really a Sport – Cue Heated Debate
Chinese Video Streamer iQiyi Targets U.S. Market With Animation on Nickelodeon
Chinese Majority Owned Lotus Announce EV Sports Car Venture With Renault’s Alpine
Chinese New Film Materials Maker HIUV on Track to Raise $227m in STAR Market IPO
Jordan Slam Dunks on Copycat Chinese Sportswear Brand Forcing Them to Change Their Name
Trending in China: Will ‘Chinese Baijiu’ Name Change Propel It To Global Dominance?
EHang Pioneers Self-Flying Drones for Tourists in Greater Bay Area City
TCL Squashes Rumours it is Withdrawing From North America Amid Empty Shelves
Chinese PE Fund Manager CICC Capital Secures $649m Second Close of Biomedicine Fund
WeRide Receives $310 Million as Beijing Opens Highways to Autonomous Car Tests
China’s Orchid Asia Leads Funding in Delivery Platform Fantuan, Edtech Startup Ivydad
U.S.-Listed Video Streamer Bilibili Files for Secondary Listing in Hong Kong, CNBC Reports
Dining Delivery Pay Dispute Leads Man to Set Himself on Fire
PayPal Becomes First Foreign Company to Offer Digital Payments in China
Tesla Rival Xpeng Motors Into New Year Fueled By New Credit Line
China’s Smartphone Shipments Fall Nearly 13% in December Amid Virus Flare-Up
Trending in China: Weibo Fails to See the ‘Funny Side’ of Sexual Harassment
Luxury Retailer Secoo Looks to Join Exodus of Chinese Companies from U.S. Stock Exchanges
Chinese Biotech Firm VISEN Raises $150m Led by Sequoia Capital China
Medical Robot Maker Finds Elixir in STAR Board’s Market Reforms

By Yang Ge / Jul 08, 2020 01:46 PM / Finance

Photo: VCG

Photo: VCG

It may still be losing money, but Chinese investors are still seeing plenty of potential in a specialist maker of robots that assist in bone surgery.

Newly listed shares of Tinavi Medical Technologies rose a massive 614% — representing a more than seven-fold increase — in their Tuesday trading debut on Shanghai’s year-old Nasdaq-style STAR Market. The gains continued, albeit at a more modest rate, on Wednesday, with the stock up another 5.8% midway through the trading day.

Tinavi priced its shares at 12.04 yuan apiece, raising about 500 million yuan ($71 million) in the process. When the dust had settled, its shares ended their first trading day at 86 yuan.

Tinavi’s rosy outlook aside, the spectacular gains owe as much to China’s experimentation with reform designed to make its stock markets less bureaucratic and more market-oriented. The STAR Market has been the first to adopt those reforms, which officially remove a 44% maximum gain limit still observed on the country’s other major markets for all newly listed stocks on their first trading day.

Tinavi accomplished its spectacular first-day rise despite the fact that it’s still losing money, as investors bet sales of its medical robots will grow quickly to pull it into the black. Last year the company reported a 33.7 million yuan loss, excluding one-time items, narrowing about 14% from the previous year.

Tinavi isn’t the only one that’s benefited from the STAR Market’s more company-friendly rules. This week leading microchip maker SMIC announced the pricing for its own massive STAR Market IPO that could raise up to $7.5 billion — the mainland’s largest listing in a decade. That listing was distinguished by the eye-popping price-to-earnings (PE) ratio of 83 that SMIC set, more than triple the informal cap currently used on the mainland’s other stock exchanges.

Contact reporter Yang Ge (

Related: SMIC Doubles Size of Shanghai Listing to $7.5 Billion

Share this article
Open WeChat and scan the QR code